Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I-II Study of Systemic Capecitabine, Cisplatin and Intraperitoneal Docetaxel (XPID) in Patients With Advanced Stomach Cancer With Peritoneal Seeding

NCT01525771 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT01525771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01525771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I-II Study of Systemic Capecitabine, Cisplatin and Intraperitoneal Docetaxel (XPID) in Patients With Advanced Stomach Cancer With Peritoneal Seeding
Lead sponsor
Asan Medical Center
Phase
Phase 1/2
Overall status
Completed
Start date
February 28, 2011
Completion date
December 31, 2014
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage iv gastric cancer with metastasis